Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-23, Stock:NVO, The news for the past five days is as follows:
2018-01-16: NEWS1: Teva's Trisenox Gets FDA Approval as First-Line Treatment.NEWS2: Eli Lilly's Risks Could Be Underappreciated, Goldman Sachs Says In Downgrade.NEWS3: The Race To Find A Treatment For NASH.NEWS4: The Race To Find A Treatment For NASH.
2018-01-17: NEWS1: Novo Nordisk's (NVO) Hits 52-Week High: What's Driving It?.NEWS2: Novo Nordisk&apos;s (NVO) Hits 52-Week High: What&apos;s Driving It?.NEWS3: Is Eli Lilly and Company a Buy in 2018?.
2018-01-18: NEWS1: Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?.NEWS2: Scoop Up Teva Pharmaceutical Industries Ltd (ADR) on Every Dip.NEWS3: Largest Ablynx investor would consider improved Novo Nordisk bid.
2018-01-19: NEWS1: European ADRs Move Higher in Friday Trading.NEWS2: European ADRs Move Higher in Friday Trading.NEWS3: The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis.NEWS4: The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis.
2018-01-22: NEWS1: Behind Novartis’s 4Q17 Estimates: Innovative Medicines.NEWS2: Behind Novartis’s 4Q17 Earnings: Why Some Expect Revenue Growth.

Answer: Decrease